Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Latest news
Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
Upcoming event
BIO-Europe Spring
March 18–20, 2024, Barcelona, Spain
March 26–27, 2024, Digital Partnering